Loading…

Tobacco Regulatory Research - Host: Biobehavioral

Select Protocol ID

The Timeline Followback (TLFB)
#720101

Bernert JT, et al. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography-tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. Anal Toxicol, 2000
#091708

Bernert JT, et al. Interlaboratory comparability of serum cotinine measurements at smoker and nonsmoker concentration levels: a round-robin study. Nicotine Tob Res, 2009
#091709

Wang L, et al. Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human Urine. CANCER EPIDEM BIOMAR, 2018
#091707

Bidwell, L.C., et al, Effects of abstinence in adolescent tobacco smokers: Withdrawal symptoms, urge, affect, and cue reactivity. NICOTINE TOB RES, 2013
#720501

Sandberg, A, et al, Assessing recent smoking status by measuring exhaled carbon monoxide levels. PLOS ONE, 2011
#720301

Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 - December 2022)
#720603

Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 - December 2022)
#720604

Pregnancy Risk Assessment Monitoring System (PRAMS), 2023 and the Population Assessment of Tobacco and Health Wave 7 Adult Survey
#720902

Xia Y, et al. Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Anal Chem., 2005
#720403

Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 - December 2022)
#720802

The Minnesota Withdrawal Scale - Revised (MWS-R)
#721001
Release Date:

February 20, 2015

Scope of Collection
Element Considered Final Measures in Toolkit
Behavior economics / purchase behavior Behavior Economics/Purchase Behavior
Cessation self-efficacy
Co-occurring use
Cue reactivity/craving Cue Reactions to Tobacco Stimuli
Decision making / delayed discounting
Dependence
Expectancies
Information seeking behavior (web, smartphone, social media, etc.)
Intentions to use/susceptibility
Knowledge
Motivation to quit Motivation to Quit - Multiple Item
Motivation to Quit - Single Item
Motives/Reasons for use
Other substance use/risky behaviors
Patterns of use Amount, Type, and Frequency of Recent Cigarette Use
Perceived norms
Perceived prevalence
Reasons to switch products History of Switching to Lower Tar and Nicotine Cigarettes
Relapse
Risk & protective factors
Risk perceptions
Biomarkers (of harm/health and exposure) Biomarker of exposure to nicotine-containing products - Saliva
Biomarker of exposure to nicotine-containing products - Serum
Biomarker of exposure to nicotine-containing products - Urine
Expired Carbon Monoxide
NNAL in Urine
Demographics
Flavor preference (e.g. menthol, clove) Flavor Preference - e-cigarettes - Adult
Flavor Preference - e-cigarettes - Youth
Genetics (family history)
Health Effects (ST, LT)
Health status (baseline and lifetime)
Metabolism/PK
Pregnancy status
Withdrawal
Working Group Roster:

WG Members:

Anne Joseph, MD, MPH, Co-Chair
University of Minnesota, Twin Cities
Division of General Internal Medicine
Minneapolis, MN
Stephanie S. O'Malley, PhD, Co-Chair
Yale University
Department of Psychology
New Haven, CT
Benjamin Blount, PhD
Centers for Disease Control and Prevention
National Center for Environmental Health Division of Laboratory Sciences
Atlanta, GA
Suzanne M. Colby, PhD
Brown University
Center for Alcohol and Addiction Studies
Providence, RI
Gary A. Giovino, PhD, MS
State University of New York at Buffalo
Department of Community Health and Health Behavior
Buffalo, NY
Stephen Hecht, PhD
University of Minnesota, Twin Cities
Department of Medicinal Chemistry
Minneapolis, MN
Peter Shields, MD
The Ohio State University
Comprehensive Cancer Center
Columbus, OH
Saul M. Shiffman, PhD
University of Pittsburgh
Pittsburgh, PA

Tobacco Regulatory Research Panel Liaison, WG Manager and WG Supervisor:

Gregory K. Farber, PhD, Tobacco Regulatory Research Panel Liaison
National Institute of Mental Health (NIMH)
Office of Technology Development and Coordination (Director)
Bethesda, MD
Gary E. Swan, PhD, Tobacco Regulatory Research Panel Liaison
Stanford University School of Medicine
Stanford, CA
Robin J. Mermelstein, PhD, Tobacco Regulatory Research Panel Liaison
University of Illinois at Chicago
Institute for Health Research and Policy
Chicago, IL
Gordon B. Willis, PhD, Tobacco Regulatory Research Panel Liaison
National Cancer Institute (NCI)
Applied Research Program
Cancer Control and Population Sciences
Rockville, MD
Darigg Brown, PhD, MPH, WG Supervisor
RTI International
Research Triangle Park, NC
Lisa Cox, MS, WG Manager
RTI International
Atlanta, GA

TCORS Liaison:

Bonnie Halpern-Feisher, PhD, MA
Stanford University
Division of Adolescent Medicine
Stanford, CA

NIH National Heart, Lung and Blood Institute Liaison:

Lisa Postow, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Bethesda, MD

FDA Center for Tobacco Products Liaison:

Lynn C. Hull, PhD
Food and Drug Administration (FDA)
Center for Tobacco Products
Silver Spring, MD
Content Expert Panel #1 - Tobacco Regulatory Research:

CEP Members:

Meghan Morean, PhD, Co-Lead
Yale University
New Haven, CT
Cassandra Stanton, PhD, Co-Lead
Westat
Rockville, MD
Neal L. Benowitz, MD
University of California, San Francisco
San Francisco, CA
Kurt Ribisl, PhD, MA
University of North Carolina at Chapel Hill
Chapel Hill, NC
Michelle Bover-Manderski, PhD
Rutgers University
New Brunswick, NJ
Brittney Keller-Hamilton, PhD
The Ohio State University
Columbus, OH
Jenny Ozga, PhD
Westat
Rockville, MD
Shyanika Rosa, PhD
University of Kentucky
Lexington, KY

SC Liaison and CEP Manager:

Tabitha P. Hendershot, BA, SC Liaison
RTI International
Washington, DC
Lisa Cox, MS, CEP Manager
RTI International
Atlanta, GA

Supplemental Information includes protocols that the Working Group or Expert Review Panel considered useful and highly relevant to the domain but do not meet the criteria for inclusion in the Toolkit.

There is no supplemental information for this collection.

Additional Information:

There is no additional information for this collection.

Measure Protocols Domain/Collection
Amount, Type, and Frequency of Recent Use of Nicotine Products Add to My Toolkit Amount, Type, and Frequency of Recent Use of Nicotine Products Tobacco Regulatory Research - Host: Biobehavioral
Biomarker of exposure to nicotine-containing products Add to My Toolkit Biomarker of exposure to nicotine-containing products - Saliva Respiratory
Add to My Toolkit Biomarker of exposure to nicotine-containing products - Serum Respiratory
Add to My Toolkit Biomarker of exposure to nicotine-containing products - Urine Respiratory
Cue Reactions to Tobacco Stimuli Add to My Toolkit Cue Reactions to Tobacco Stimuli Tobacco Regulatory Research - Host: Biobehavioral
Expired Carbon Monoxide Add to My Toolkit Expired Carbon Monoxide Tobacco Regulatory Research - Host: Biobehavioral
Flavor Preference - e-cigarettes Add to My Toolkit Flavor Preference - Electronic Nicotine Products - Adults Tobacco Regulatory Research - Host: Biobehavioral
Add to My Toolkit Flavor Preference - electronic nicotine products - Youth Tobacco Regulatory Research - Host: Biobehavioral
Pregnancy Status - Mother and Baby Health Add to My Toolkit Mother and Baby Health Tobacco Regulatory Research - Host: Biobehavioral
NNAL in Urine Add to My Toolkit NNAL in Urine Tobacco Regulatory Research - Host: Biobehavioral
Pregnancy Status and Tobacco Use Add to My Toolkit Pregnancy Status and Tobacco Use Tobacco Regulatory Research - Host: Biobehavioral
Withdrawal from Tobacco Use Add to My Toolkit Withdrawal from Tobacco Use Tobacco Regulatory Research - Host: Biobehavioral